Product information

From Health Canada

New search

Current status:

Cancelled Post Market

Current status date:

2016-09-30

Original market date: ^{See footnote 1}

2014-01-06

Lot number: ^{See footnote 2}

20MO03

Expiry date: ^{See footnote 2}

2017-10-31

Product name:

SUBLIME SUN LOTION SPF 30

DIN:

02394057 Electronic product monograph is not available

Company:

L'OREAL CANADA
4895 Rue Hickmore
Montreal
Quebec
Canada H4T 1K5

Class:

Human

Dosage form(s):

Lotion

Route(s) of administration:

Topical

Number of active ingredient(s):

Schedule(s):

NON-PRESCRIPTION DRUGS

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION

Active ingredient group (AIG) number:^{See footnote5}

0544758065

List of active ingredient(s)
Active ingredient(s) ^{See footnote8}	Strength
AVOBENZONE	3 % / W/W
HOMOSALATE	15 % / W/W
OCTISALATE	5 % / W/W
OCTOCRYLENE	5 % / W/W
OXYBENZONE	6 % / W/W

New search

Same active ingredient group number

Footnotes

Footnote 1

The earliest marketed date recorded in the Drug Product Database.

Return to footnote 1referrer

Footnote 2

When a manufacturer decides to discontinue the sale of their drug, the date of discontinuation is the date of the last sale by the manufacturer. The DIN will be cancelled further to the receipt of a sale discontinuation notification from the manufacturer. The status of the DIN will be updated to “Cancelled (Post-Market)” in the online Drug Product Database. For DINs cancelled on or after March 14, 2017, the latest expiry date and lot number of the product distributed in Canada will be posted on the online Drug Product Database. Other parties in the health product distribution chain such as wholesalers, retailers, pharmacists and medical practitioners may still sell or distribute that drug after DIN cancellation if the expiry date of the drug lot has not passed. This may be acceptable so long as the DIN cancellation is not due to health and/or safety reasons.

Return to footnote 2referrer

Footnote 4

The purpose of the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system is to be used as a tool for drug utilization research in order to improve quality of drug use. Drugs are divided into different groups according to the organ or system on which they act and their chemical, pharmacological and therapeutical properties.

Return to footnote 4referrer

Footnote 5

The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIG is comprised of three portions:

the first portion (2 digits) identifies the number of active ingredients,
the second portion (5 digits) identifies the unique groups of active ingredients(s),
the last portion (3 digits) identifies the active ingredient group strength. The strength group has a tolerance of ‑2% to +10%.

Return to footnote 5referrer

Footnote 8

An asterisk * preceding an active ingredient indicates that the name of the active ingredient has been shortened to fit inside the database's field and that the active ingredient's full name is available on the product's Product Monograph/Veterinary Labelling available above and/or in the NOTES section of the QRYM_ACTIVE_INGREDIENTS extract available in the Drug product database (DPD) data extracts. The following link provides an explanation of the ordering of the data values contained in the DPD data extracts Read me file.

Return to footnote 8referrer

Application information

Related information

Contact us

Version 4.1.0

"Page details"

Date modified:: 2019-03-01